Ashim Subedee

512 citations
6 papers · 332 · 1 hit paper · h-index 4

Impact in

    • Cancer Genomics and Diagnostics
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Epigenetics and DNA Methylation 1
    • Protein Degradation and Inhibitors 1
    • Cancer Cells and Metastasis 2
    • CAR-T cell therapy research 1

Ashim Subedee

5 papers receiving 329 citations

Ashim Subedee's Hit Papers

Trends in the approval of cancer therapies by the FDA in the twenty-first century 2023 · 155 citations
1550+1+2Years since publication50100150

Peers

Ashim Subedee
Comparison fields: 5 of 74
  • Cancer Research 62
  • Oncology 96
  • Plant Science 75
  • Molecular Biology 124
  • Immunology 34
Replace Allison Moyer with:
Allison Moyer United States
Limin Huang China
Brock J. McKinney United States
Keisha Milum United States
Yanzhou Zhang Singapore
Pekka Haapaniemi Finland
Zhigang Charles Wang United States
Toni M. Yeasky United States
Yidan Ma China
Ashim Subedee relative to Allison Moyer United States Allison Moyer's profile →
Citations per field
00.5×4.4×
Allison Moyer · 1×
Citations per year

Countries citing papers authored by Ashim Subedee

Since Specialization
Citations

This map shows the geographic impact of Ashim Subedee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashim Subedee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashim Subedee more than expected).

Fields of papers citing papers by Ashim Subedee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashim Subedee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashim Subedee. The network helps show where Ashim Subedee may publish in the future.

Co-authors

The 25 scholars most cited alongside Ashim Subedee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashim Subedee Line = papers co-authored together Ashim Subedee links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Trends in the approval of cancer therapies by the FDA in the twenty-first century
Hit paper breakdown →
2023155
2 200774
3 201553
4 201947
5 20213
6 20200

About Ashim Subedee

Ashim Subedee is a scholar working on Molecular Biology, Oncology, Cancer Research, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 332 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Cancer Cells and Metastasis (2 papers), Epigenetics and DNA Methylation (1 paper), Advanced Breast Cancer Therapies (1 paper), CAR-T cell therapy research (1 paper), Protein Degradation and Inhibitors (1 paper), Plant-Microbe Interactions and Immunity (1 paper) and Plant Pathogens and Fungal Diseases (1 paper). The work is most often cited by research in Cancer Research (62 citations), Oncology (96 citations), Plant Science (75 citations), Molecular Biology (124 citations) and Immunology (34 citations). Ashim Subedee has collaborated with scholars based in United States, Japan and Denmark. Frequent co-authors include Li Wang, Adam J. Bogdanove, Richard Pazdur, Haleh Saber, Andrea Baines, V. Ashutosh Rao, Julie A. Schneider, Gülsüm Emel Pamuk, Wenming Xiao and Emma Scott. Their work appears in journals such as Nature Reviews Drug Discovery, Journal of Clinical Oncology, Applied and Environmental Microbiology, Clinical and Translational Science and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact